Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Beatriz Paradela Dobarro"'
Autor:
Sergio Raposeiras Roubín, Cristina Barreiro Pardal, Filomena Roubín-Camiña, Raymundo Ocaranza Sanchez, Ezequiel Álvarez Castro, Beatriz Paradela Dobarro, Jose María García-Acuña, Pablo Aguiar Souto, Michel Jacquet Hervet, Maria José Castromán, Isabel Arufe, Belén Outes, María Victoria Reino-Maceiras, Emad Abu Assi, José Ramón González-Juanatey
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 32, Iss 2, Pp 117-122 (2013)
Introduction: Atherosclerosis is an active process and the inflammatory component appears to be particularly correlated with the development of acute coronary syndromes (ACS). C-reactive protein (CRP) is an acute phase protein that appears in the cir
Externí odkaz:
https://doaj.org/article/d162e6041f60418ab71c12afff2500ed
Autor:
Beatriz Paradela-Dobarro, Susana B. Bravo, Adriana Rozados-Luís, Mercedes González-Peteiro, Alfonso Varela-Román, José Ramón González-Juanatey, Javier García-Seara, Ezequiel Alvarez
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 113, Iss , Pp - (2019)
Objectives: Characterization of the type of glycation found in circulating proteins from cardiovascular patients in comparison with healthy control subjects and to explore the pathophysiological molecular effects of these glycomodified proteins on hu
Externí odkaz:
https://doaj.org/article/f2406c6801e9412ea6af7a40ce59f3ad
Autor:
Francisco Javier García-Seara, Leyre Álvarez, Rosa M. Agra, Alfonso Varela-Román, Beatriz Paradela-Dobarro, José Ramón González-Juanatey, Ezequiel Álvarez, José María García-Acuña
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 29:1050-1060
Aims This work aimed to compare the behavior of the advanced glycation end products (AGEs) and their soluble receptor (sRAGE) in two cohorts of patients: those with heart failure (HF) and acute coronary syndrome (ACS). Methods and results A unicentri
Autor:
Sonia Eiras, María Torres-Español, Manuel Calaza, Manuela Gago-Dominguez, Alfonso Varela-Román, José Ramón González-Juanatey, Ángel Fernández-Trasancos, Rosa M. Agra, Angel Carracedo, L. Alvarez, Ezequiel Álvarez, Beatriz Paradela-Dobarro
Publikováno v:
Cardiovascular Drugs and Therapy. 33:415-424
Recent advances in genomics offer a smart option for predicting future risk of disease and prognosis. The objective of this study was to examine the prognostic value in heart failure (HF) patients, of a series of single nucleotide polymorphisms (SNPs
Autor:
María Moure-Álvarez, José Ramón González-Juanatey, María Cebro-Márquez, Ezequiel Álvarez, Beatriz Paradela-Dobarro, Isabel Moscoso, Alfredo Redondo, Javier García-Seara
Publikováno v:
Journal of Molecular Medicine.
Autor:
Sergio Raposeiras-Roubín, Bruno K Rodiño-Janeiro, Beatriz Paradela-Dobarro, Lilian Grigorian-Shamagian, José M García-Acuña, Pablo Aguiar-Souto, Michel Jacquet-Hervet, María V Reino-Maceiras, José R González-Juanatey, Ezequiel Álvarez
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74302 (2013)
ObjectiveAdvanced glycation end products (AGEs) have pathophysiological implications in cardiovascular diseases. The aim of our study was to evaluate the prognostic value of fluorescent AGEs and its soluble receptor (sRAGE) in the context of acute co
Externí odkaz:
https://doaj.org/article/e9d1cb361344473b8e3e8cf84712cd36
Autor:
Javier García-Seara, María Moure-Álvarez, Ezequiel Álvarez, José Ramón González-Juanatey, Alfredo Redondo, María Cebro-Márquez, Beatriz Paradela-Dobarro, Isabel Moscoso
Publikováno v:
Journal of Molecular Medicine (Berlin, Germany)
Post-infarction remodeling is a clinical problem with no curative treatment. Our objective was to search for new biomarkers of cardiac remodeling that have clinical value after ST-segment elevation myocardial infarction (STEMI). This pilot study enro
Autor:
Ezequiel Álvarez, José Ramón González-Juanatey, Sergio Raposeiras-Roubín, Beatriz Paradela-Dobarro
Publikováno v:
British Journal of Clinical Pharmacology. 84:280-291
Aims: Rivaroxaban, a direct inhibitor of activated factor X (FXa), is the only new oral anticoagulant approved for secondary prevention after acute coronary syndrome. Our objective was to identify the possible molecular mechanisms of rivaroxaban that
Autor:
Bryan Veeren, Olivier Meilhac, Susana B. Bravo, Philippe Rondeau, Anne Devin, Pascal Baret, Wildriss Viranaicken, Beatriz Paradela-Dobarro, Ezequiel Álvarez, Anthony Dobi
Publikováno v:
Free Radical Research
Free Radical Research, Taylor & Francis, 2019, 53 (2), pp.150-169. ⟨10.1080/10715762.2018.1529866⟩
Free Radical Research, Taylor & Francis, 2019, 53 (2), pp.150-169. ⟨10.1080/10715762.2018.1529866⟩
Advanced glycation end-products (AGEs) trigger multiple metabolic disorders in the vessel wall that may in turn lead to endothelial dysfunction. The molecular mechanisms by which AGEs generate these effects are not completely understood. Oxidative st
Autor:
Sergio Raposeiras-Roubín, Beatriz Paradela-Dobarro, Mercedes González-Peteiro, Bruno K. Rodiño-Janeiro, José Ramón González-Juanatey, Jana Alonso, Ezequiel Álvarez
Publikováno v:
Journal of Molecular Endocrinology. 56:23-37
Most of the studies on advanced glycation end products (AGE) have been carried out with uncharacterized mixtures of AGE, so the observed effects cannot be linked to defined structures. Therefore, we analysed the structural differences between glycate